The FTC found that 22 percent of specialty drugs dispensed by PBM-affiliated pharmacies were marked up by more than 1,000 percent while 41 percent were marked up between 100 and 1,000 percent.

Without federal action to create transparency in the PBM market consumers will continue to pay higher prices for their medicine. PBMs act as a middleman between other institutions in the ...

If the FTC were to take action to break up the PBM market, of which 80 percent is controlled by three operators, that could potentially benefit WBA significantly. The recent study released by the ...